The emergence of methicillin-resistant Staphylococcus aureus (MRSA) as a recognized cause of community-acquired and hospital infections has brought about a need for the efficient and accurate identification of peptides with anti-MRSA properties in drug discovery and development pipelines. However, current experimental methods often tend to be labor- and resource-intensive. Thus, there is an immediate requirement to develop practical computational solutions for identifying sequence-based anti-MRSA peptides. Lately, pre-trained protein language models (pLMs) have emerged as a remarkable advancement for encoding peptide sequences as discriminative feature embeddings, uncovering plentiful protein-level information and successfully repurposing it for in silico peptide property prediction. In this study, we present pLM4MRSA, a framework based on pLMs designed to enhance the accuracy of predicting anti-MRSA peptides. In this framework, we combine feature embeddings from various pLMs, such as ProtTrans, and evolutionary-scale modeling (ESM-2) which provide complementary information for prediction. These individual pLM strengths are integrated to form hybrid feature embeddings. Next, we apply principal component analysis (PCA) to process these hybrid embeddings. The resulting PCA-transformed feature vectors are then used as inputs for constructing the predictive model. Experimental results on the independent test dataset showed that the proposed pLM4MRSA approach achieved a balanced accuracy and Matthew correlation coefficient of 0.983 and 0.980, respectively, representing remarkable improvements over the state-of-the-art methods by 2.53%-4.83% and 7.73%-13.23%, respectively. This indicates that pLM4MRSA is a high-performance prediction model with excellent scope of applicability. Additionally, comparison with well-known hand-crafted features demonstrated that the proposed hybrid feature embeddings complement each other effectively, capturing discriminative patterns for more accurate anti-MRSA peptide prediction. We anticipate that pLM4MRSA will serve as an effective solution for accurate and high-capacity prediction of anti-MRSA peptides from peptide sequences.